Adding an investigational drug to an already approved estrogen blocking therapy appears to be safe and provided clinical benefit for some postmenopausal women with estrogen-positive breast cancer.
Kelly Wolenberg, a third-year medical student at the Vanderbilt University School of Medicine, has been named to take part in the 2015 Fellowships at Auschwitz for the Study of Professional Ethics (FASPE).
Patients seeking to participate in clinical trials have a new option in online tools for finding studies that might offer hope for their problem or condition.
Sir Stephen O’Rahilly, M.D., an expert in metabolic and endocrine diseases, will deliver the next Flexner Discovery Lecture on Thursday, April 2.
Nominations for this year’s Vanderbilt Prize Scholar are now being accepted. The deadline is April 24.